🇺🇸 FDA
Patent

US 9624509

Modulation of stem cells using zinc finger proteins

granted A61KA61K35/12A61K35/545

Quick answer

US patent 9624509 (Modulation of stem cells using zinc finger proteins) held by Sangamo Biosciences, Inc. expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K35/12, A61K35/545, A61P, A61P35/00